Citation Formats
New treatment options in castration resistant prostate cancer: enzalutamide and abiraterone acetate
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. AKDOĞAN, "New treatment options in castration resistant prostate cancer: enzalutamide and abiraterone acetate," UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.12, no.2, pp.111-114, 2013

AKDOĞAN, B. 2013. New treatment options in castration resistant prostate cancer: enzalutamide and abiraterone acetate. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.12, no.2 , 111-114.

AKDOĞAN, B., (2013). New treatment options in castration resistant prostate cancer: enzalutamide and abiraterone acetate. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.12, no.2, 111-114.

AKDOĞAN, BÜLENT. "New treatment options in castration resistant prostate cancer: enzalutamide and abiraterone acetate," UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.12, no.2, 111-114, 2013

AKDOĞAN, BÜLENT. "New treatment options in castration resistant prostate cancer: enzalutamide and abiraterone acetate." UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.12, no.2, pp.111-114, 2013

AKDOĞAN, B. (2013) . "New treatment options in castration resistant prostate cancer: enzalutamide and abiraterone acetate." UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.12, no.2, pp.111-114.

@article{article, author={BÜLENT AKDOĞAN}, title={New treatment options in castration resistant prostate cancer: enzalutamide and abiraterone acetate}, journal={UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY}, year=2013, pages={111-114} }